Fosaprepitant News
Fosaprepitant currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Fosaprepitant with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults and paediatric patients aged 6 months and older. Ivemend 150 mg is given as part of a...
- Evidence level: L5
- Predicted indications (20):
- nephrogenic syndrome of inappropriate antidiuresis (99.9%)
- pneumocystosis (99.9%)
- leprosy (99.8%)
- Cryptococcal meningitis (99.8%)
- multiple endocrine neoplasia (99.8%)
- intracranial abscess (99.8%)
- retinitis (99.7%)
- Plasmodium falciparum malaria (99.6%)
- echinococcus granulosus infectious disease (99.5%)
- hyperargininemia (99.4%)
- hypertrichosis (disease) (99.4%)
- cysticercosis (99.4%)
- acute neonatal citrullinemia type I (99.3%)
- adult-onset citrullinemia type I (99.3%)
- malaria (99.2%)
- persistent Mullerian duct syndrome (99.2%)
- HIV infectious disease (99.2%)
- syndrome with a Dandy-Walker malformation as major feature (99.2%)
- motor nerve neuritis (99.2%)
- malformation syndrome with odontal and/or periodontal component (99.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.